InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,746.20
(
0.42%
)
US TECH 100
19,585.60
(
0.79%
)
Dow Jones
42,182.63
(
0.64%
)
Brent Oil
70.97
(
-3.04%
)
Bitcoin
65,242.31
(
3.34%
)
Post# of 429108
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sts66

Send PM Follow Ignore
Followers 74
Posts 15848
Boards Moderated 0
Alias Born 04/26/2010

sts66

Re: retinadoc post# 348839

Monday, 08/02/2021 5:54:52 PM

Monday, August 02, 2021 5:54:52 PM

Post# of 429108
R-IT did not have multiple studies indicating success was in the cards - there was only one, JELIS - all others were mixed O3's that pointed towards failure, which is why jerks like Nissen refused to believe R-IT results were valid - they went against the findings of nearly every preceding O3 trial.

The Thought Police: To censor and protect. Craig Bruce

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!